New cases tested for RR-/MDR-TB in Iran, Islamic Republic of

Iran, Islamic Republic of: New cases tested for RR-/MDR-TB was 80.0% in 2024. ◆ Volatile

Latest (2024)
80.0%
Change on year
up 95.1%
World rank
127th
of 192 countries
All-time high
80.0%
in 2024
All-time low
4.3%
in 2008
Years of data
19
2005–2024

New cases tested for RR-/MDR-TB in Iran, Islamic Republic of, 2005–2024

0204060802005201420242005: 4.52006: 92007: 8.22008: 4.32010: 4.72011: 132012: 6.82013: 9.52014: 202015: 182016: 212017: 682018: 612019: 632020: 452021: 472022: 622023: 412024: 80

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for new cases tested for rr-/mdr-tb in Iran, Islamic Republic of is 80.0%, measured in 2024. That is the highest value across all 19 years on record.

The figure is up 95.1% on the previous year and up 300.0% over ten years.

Over the whole period, new cases tested for rr-/mdr-tb in Iran, Islamic Republic of peaked at 80.0% in 2024 and was at its lowest, 4.3%, in 2008.

That places Iran, Islamic Republic of 127th out of 192 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

New cases tested for RR-/MDR-TB in Iran, Islamic Republic of, year by year

Annual values for New cases tested for RR-/MDR-TB (%) in Iran, Islamic Republic of, 2005 to 2024.
Year Value Change
2005 4.5%
2006 9.0% +100.0%
2007 8.2% -8.9%
2008 4.3% -47.6%
2010 4.7% +9.3%
2011 13.0% +176.6%
2012 6.8% -47.7%
2013 9.5% +39.7%
2014 20.0% +110.5%
2015 18.0% -10.0%
2016 21.0% +16.7%
2017 68.0% +223.8%
2018 61.0% -10.3%
2019 63.0% +3.3%
2020 45.0% -28.6%
2021 47.0% +4.4%
2022 62.0% +31.9%
2023 41.0% -33.9%
2024 80.0% +95.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 6.5% 4.3% 9.0% 4
2010s 28.5% 4.7% 68.0% 10
2020s 55.0% 41.0% 80.0% 5

Countries ranked near Iran, Islamic Republic of

  1. 126 Nigeria 81.0% compare
  2. 127 Malawi 80.0% compare
  3. 127 Latvia 80.0% compare
  4. 130 Philippines 79.0% compare

See the full ranking of 204 places →

More health data for Iran, Islamic Republic of

All data for Iran, Islamic Republic of →

Frequently asked questions

What is new cases tested for rr-/mdr-tb in Iran, Islamic Republic of?
New cases tested for rr-/mdr-tb in Iran, Islamic Republic of was 80.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest new cases tested for rr-/mdr-tb recorded in Iran, Islamic Republic of?
The highest recorded value was 80.0% in 2024.
What is the lowest new cases tested for rr-/mdr-tb recorded in Iran, Islamic Republic of?
The lowest recorded value was 4.3% in 2008.
How does Iran, Islamic Republic of rank for new cases tested for rr-/mdr-tb?
Iran, Islamic Republic of ranks 127th out of 192 countries with data for 2024.
Is new cases tested for rr-/mdr-tb rising or falling in Iran, Islamic Republic of?
Over the last ten years it is up 300.0%. The long-run trend across the full record is volatile.
Where does this Iran, Islamic Republic of data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

New cases tested for RR-/MDR-TB in Iran, Islamic Republic of. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 25 August 2026, from https://health.statizoid.com/stat/new-cases-tested-for-rr-mdr-tb-percent/iran-islamic-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/new-cases-tested-for-rr-mdr-tb-percent/iran-islamic-rep/">New cases tested for RR-/MDR-TB in Iran, Islamic Republic of</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
204 places, 3,368 data points, 2005–2024
Last refreshed